Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Jun 2024 for OSE Immunotherapeutics, €36k. Read the official filing
Filing timeline
BuySaleDominique Costantini
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
Closed purchases
Market purchases
1
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -29.6%Entry €9.86 · Close at T+365 €6.95
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Dominique Costantini: trading record in brief
This profile gathers the share dealings of Dominique Costantini in OSE Immunotherapeutics, where the filings describe the role as chief executive. In total, 2 filings cover trades dated from 8 June 2021 to 17 June 2024.
Every open-market trade on record is a purchase: 1 purchase worth €203k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 1 option exercise.
On 18 June 2024 came the latest disclosure, an option exercise for €36k in OSE Immunotherapeutics. The latest purchase dates back some time: it was published 1,774 days ago, on 8 December 2021. Every figure here comes from the filings published by AMF and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Dominique Costantini
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
10,000 shares@ €3.5715.0% of flowActionEuronext ParisISIN FR00121271732024DD971661
18,500 shares@ €10.957885.0% of flowActionEuronext ParisISIN FR00121271732021DD759546
Canonical exit: 6 Sept 2021 (T+90)
2 of 2 declarations
